The Top 10 S&P 500 Stocks Holding Back the Index
While the broad markets are just barely positive for the year after a devastating October, here are the worst 10 stocks in the S&P 500 that have held the index back.
All Work
Chris Lange
Nektar Therapeutics and Pfizer Team Up in Cancer Collaboration
Nektar shares dipped on Tuesday after the company announced that it would be collaborating with Pfizer to evaluate several combination regimens in multiple cancer settings.
Can Match Keep the Rally Going in Q3?
Match is scheduled to release its third-quarter financial results after the markets close on Tuesday, and consensus estimates suggest strong growth on the top and bottom lines.
Eli Lilly Dips Despite Solid Q3 Results
Eli Lilly released better-than-expected third-quarter financial results before the markets opened on Tuesday.
Why Regulus Therapeutics Is Booming
Regulus Therapeutics shares shot up on Tuesday after the company announced that it had amended and restructured its collaboration and license agreement with Sanofi.
What Drove Mylan Earnings in Q3
Mylan reported better-than-expected quarterly results late Monday, and shares rose sharply in Friday's premarket.
Monday’s Biggest Winners and Losers in the S&P 500
Monday was a mixed day for the broad U.S. markets. With October clearly in the rearview, the Dow Jones Industrial Average and the S&P 500 pushed higher, although the Nasdaq lagged in the session.…
SeaWorld Q3 Turnaround Not Enough for Investors
SeaWorld released better-than-expected third-quarter financial results before the markets opened on Monday.
Vapotherm Gears Up for IPO
Medical technology company Vapotherm intends to price 4 million shares for and initial public offering valued up to more than $73 million.
FedEx Plans to Raise Rates in 2019
FedEx shares were up slightly on Monday after the company announced that it would raising its shipping rates to kick off 2019.
What to Watch For When Eli Lilly Reports Tuesday Morning
Eli Lilly is scheduled to release its most recent quarterly results before the markets open on Tuesday.
Sysco Disappoints for Q1: What’s Next?
Sysco shares retreated after the company released its most recent quarterly results before the markets opened on Monday.
Why Clearside Biomedical Shares Were Halved
Clearside Biomedical shares were halved early on Monday after the firm reported results from its late-stage Sapphire trial.
A List of All 20 US Stores Lowe’s Is Closing
Lowe’s shares were relatively unchanged on Monday morning after the home improvement chain announced that it would be closing just over 50 locations in the United States and Canada.
Why Weight Watchers Is Friday’s Big Earnings Loser
Weight Watchers reported its third quarter financial results after the markets closed on Thursday. The company said that it had $1.00 in earnings per share (EPS) on $365.8 million in revenue, compared with consensus…
AbbVie Little Changed Despite Big Bottom-Line Beat
AbbVie released its third quarter financial results before the markets opened on Friday. The pharma giant said that it had $2.14 in earnings per share (EPS) and $8.24 billion in revenue, compared with consensus…
Why the FDA Is Dragging Alkermes Down
Alkermes shares dropped early on Friday after the company anncounced the results from its most recent meeting with the U.S. Food and Drug Administration.
Why GoPro’s Q3 Isn’t Good Enough
GoPro reported its most recent quarterly results after the markets closed on Thursday. The company said that it had a net loss of $0.04 per share and $285.9 million in revenue, compared with consensus…
Why Apple is Sliding
Apple released its most recent quarterly results after the markets closed on Thursday. The iPhone giant said that it had $2.91 in earnings per share (EPS) and $61.1 in revenue, compared with consensus estimates…
Thursday’s Biggest Winners and Losers in the S&P 500
Wednesday was another solid day for the broad U.S. markets. October’s scare didn’t mean much for Thursday. Crude oil saw another dip. The S&P 500 was largely positive.